MedTrace Logo

Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

NCT05782985 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2023-07-25

No results posted yet for this study

Summary

The aim of the study is to evaluate the expression pattern of heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) and K (HNRNPK) genes in Myeloproliferative neoplasms as a possible indicator of disease progression and as a potential therapeutic target

Conditions

  • Myeloproliferative Neoplasms (MPNs)

Interventions

DIAGNOSTIC_TEST

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Blood samples from the myeloproliferative neoplasms cases and the controls will be tested with Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) for expression of heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) and K (HNRNPK) genes.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Alaa Elminshawy, MD, Mac · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-20
Primary Completion
2025-03-20
Completion
2025-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05782985 on ClinicalTrials.gov